The new frontier of genome engineering with CRISPR-Cas9
Новый рубеж геномного редактирования с помощью CRISPR-Cas9
2014-11-28
SCID: 54.1/zkutr4y6
Discuss with AI
CRISPR-Cas9RNA-guided genome engineeringclustered regularly interspaced palindromic repeatgenome engineering applicationsgenomic locus modification
Figures from the paper
Abstract (AI)
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Key Findings
1
CRISPR-Cas9 is applicable across a wide variety of cells and organisms from all three domains of life.
2
CRISPR-Cas9 provides a facile, RNA-guided method for genome engineering in animals and plants.
3
CRISPR-Cas9 technology has broad applications in biotechnology and potential strategies for human therapeutics.
4
Genome manipulation using CRISPR-Cas9 removes a major experimental bottleneck, accelerating fundamental biological discoveries.
5
Understanding of CRISPR biology and Cas9 enzyme mechanism enabled developments to modify, regulate, or mark genomic loci.
Research Object
CRISPR-Cas9 genome engineering system applied to animals and plants
Research Subject
Capabilities and applications of CRISPR-Cas9 for modifying, regulating, and marking genomic loci across diverse cells and organisms
Publication Details
Publication Date
2014-11-28
Journal
Publisher
ISSN
Cited by
7042
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai5
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes2007
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells2013
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins2014
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin2005
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases2013
Cited by10
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects2020
The CRISPR tool kit for genome editing and beyond2018
Gene therapy comes of age2018
The role of the microbiome in cancer development and therapy2017
A Method for the Acute and Rapid Degradation of Endogenous Proteins2017
Advances in therapeutic CRISPR/Cas9 genome editing2015
Synthetic Biology—The Synthesis of Biology2016
Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting2017
FDA orphan drug designations for lysosomal storage disorders – a cross-sectional analysis2020
Candidate Genes, Markers, Signatures of Selection, and Quantitative Trait Loci (QTLs) and Their Association with Economic Traits in Livestock: Genomic Insights and Selection2025